MiR-512-5p induces apoptosis and inhibits glycolysis by targeting p21 in non-small cell lung cancer cells

International Journal of Oncology

Volumn 48, Issue 2, 2016, Pages 577-586

  Chu, Kaili ^a   Gao, Guanghui ^b   Yang, Xiufang ^a   Ren, Shengxiang ^b   Li, Yao ^a   Wu, Hai ^a   Huang, Yan ^a   Zhou, Caicun ^b  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Glycolysis; Migration; MiR 512 5p; P21

Indexed keywords

DIMETHYL SULFOXIDE; GLUCOSE; LACTIC ACID; MICRORNA; MICRORNA 512 2P; PROTEIN P21; RETINOIC ACID; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MESSENGER RNA; MIRN512 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; BINDING SITE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENERGY METABOLISM; GENE OVEREXPRESSION; GENE SILENCING; GENOMIC FRAGMENT; GLUCOSE INTAKE; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER CELL LINE; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WILD TYPE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOLYSIS; HUMANS; LUNG NEOPLASMS; MICRORNAS; RNA, MESSENGER;

EID: 84956951294     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3279     Document Type: Article

References (37)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin 65: 87-108, 2015.
2. Li J, Bi L, Sun Y, Lu Z, Lin Y, Bai O and Shao H: Text mining and network analysis of molecular interaction in non-small cell lung cancer by using natural language processing. Mol Biol Rep 41: 8071-8079, 2014.
3. Joshi P, Jeon YJ, Laganà A, Middleton J, Secchiero P, Garofalo M and Croce CM: MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC. Proc Natl Acad Sci USA 112: 8650-8655, 2015.
4. Li Y, Zhang D, Chen C, Ruan Z, Li Y and Huang Y: MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. Mol Biol Cell 23: 1423-1434, 2012.
5. Mendell JT: miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222, 2008.
6. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack FJ: RAS is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005.
7. Loo JM, Scherl A, Nguyen A, Man FY, Weinberg E, Zeng Z, Saltz L, Paty PB and Tavazoie SF: Extracellular metabolic energetics can promote cancer progression. Cell 160: 393-406, 2015.
8. Okazawa H, Shimizu J, Kamei M, Imafuku I, Hamada H and Kanazawa I: Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells. J Cell Biol 132: 955-968, 1996.
9. Burnett A, Wetzler M and Löwenberg B: Therapeutic advances in acute myeloid leukemia. J Clin Oncol 29: 487-494, 2011.
10. Fisher JN, Terao M, Fratelli M, Kurosaki M, Paroni G, Zanetti A, Gianni M, Bolis M, Lupi M, Tsykin A, et al: MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells. Oncotarget 6: 13176-13200, 2015.
11. Khan S, Wall D, Curran C, Newell J, Kerin MJ and Dwyer RM: MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid. BMC Cancer 15: 345, 2015.
12. Lichner Z, Páll E, Kerekes A, Pállinger E, Maraghechi P, Bosze Z and Gócza E: The miR-290-295 cluster promotes pluripotency maintenance by regulating cell cycle phase distribution in mouse embryonic stem cells. Differentiation 81: 11-24, 2011.
13. Cheung TH, Man KN, Yu MY, Yim SF, Siu NS, Lo KW, Doran G, Wong RR, Wang VW, Smith DI, et al: Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 11: 2876-2884, 2012.
14. Saito Y, Suzuki H, Tsugawa H, Nakagawa I, Matsuzaki J, Kanai Y and Hibi T: Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene 28: 2738-2744, 2009.
15. Sherr CJ and Roberts JM: CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999.
16. Deng C, Zhang P, Harper JW, Elledge SJ and Leder P: Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684, 1995.
17. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
18. Abbas T and Dutta A: p21 in cancer: Intricate networks and multiple activities. Nat Rev Cancer 9: 400-414, 2009.
19. Zhu X, Gao G, Chu K, Yang X, Ren S, Li Y, Wu H, Huang Y and Zhou C: Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer. Int J Biochem Cell Biol 61: 103-114, 2015.
20. Vander Heiden MG, Cantley LC and Thompson CB: Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324: 1029-1033, 2009.
21. Chen J and Thompson LU: Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro. Breast Cancer Res Treat 80: 163-170, 2003.
22. Zhang J, Attar E, Cohen K, Crumpacker C and Scadden D: Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells. Gene Ther 12: 1444-1452, 2005.
23. Rao A, Coan A, Welsh JE, Barclay WW, Koumenis C and Cramer SD: Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells. Cancer Res 64: 2143-2147, 2004.
24. Adi Harel S, Bossel Ben-Moshe N, Aylon Y, Bublik DR, Moskovits N, Toperoff G, Azaiza D, Biagoni F, Fuchs G, Wilder S, et al: Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth. Cell Death Differ 22: 1328-1340, 2015.
25. di Masi A, Leboffe L, De Marinis E, Pagano F, Cicconi L, Rochette-Egly C, Lo-Coco F, Ascenzi P and Nervi C: Retinoic acid receptors: From molecular mechanisms to cancer therapy. Mol Aspects Med 41: 1-115, 2015.
26. Chen F, Cao Y, Qian J, Shao F, Niederreither K and Cardoso WV: A retinoic acid-dependent network in the foregut controls formation of the mouse lung primordium. J Clin Invest 120: 2040-2048, 2010.
27. Jones RG and Thompson CB: Tumor suppressors and cell metabolism: A recipe for cancer growth. Genes Dev 23: 537-548, 2009.
28. Muñoz-Pinedo C, El Mjiyad N and Ricci JE: Cancer metabolism: Current perspectives and future directions. Cell Death Dis 3: e248, 2012.
29. El Mjiyad N, Caro-Maldonado A, Ramírez-Peinado S and Muñoz-Pinedo C: Sugar-free approaches to cancer cell killing. Oncogene 30: 253-264, 2011.
30. Raina K, Agarwal C, Wadhwa R, Serkova NJ and Agarwal R: Energy deprivation by silibinin in colorectal cancer cells: A double-edged sword targeting both apoptotic and autophagic machineries. Autophagy 9: 697-713, 2013.
31. Li R, Waga S, Hannon GJ, Beach D and Stillman B: Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537, 1994.
32. Delavaine L and La Thangue NB: Control of E2F activity by p21Waf1/Cip1. Oncogene 18: 5381-5392, 1999.
33. Coqueret O and Gascan H: Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/ SDI1. J Biol Chem 275: 18794-18800, 2000.
34. Kitaura H, Shinshi M, Uchikoshi Y, Ono T, Iguchi-Ariga SM and Ariga H: Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J Biol Chem 275: 10477-10483, 2000.
35. Roninson IB: Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): Association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179: 1-14, 2002.
36. Dotto GP: p21(WAF1/Cip1): More than a break to the cell cycle? Biochim Biophys Acta 1471: M43-M56, 2000.
37. Gartel AL: The conflicting roles of the cdk inhibitor p21(CIP1/ WAF1) in apoptosis. Leuk Res 29: 1237-1238, 2005.